PM359
Prime-0101
Phase 2 mab active
Quick answer
PM359 for Chronic Granulomatous Disease is a Phase 2 program (mab) at Prime Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Prime Medicine
- Indication
- Chronic Granulomatous Disease
- Phase
- Phase 2
- Modality
- mab
- Status
- active